BACKGROUND/AIMS: The development of colorectal cancer and a variable range of extracolonic manifestations in familial adenomatous polyposis (FAP) is the result of the dominant inheritance of adenomatous polyposis coli (APC) gene mutations. In this study, direct mutation analysis of the APC gene was performed to determine genotype-phenotype correlations for nine extracolonic manifestations and to investigate the incidence of APC mutations in non-FAP colorectal cancer. METHODS: The APC gene was analysed in 190 unrelated FAP and 15 non-FAP colorectal cancer patients using denaturing gradient gel electrophoresis, the protein truncation test, and direct sequencing. RESULTS: Chain terminating signals were only identified in patients belonging to the FAP group (105 patients). Amino acid changes were identified in four patients, three of whom belonged to the non-FAP group of colorectal cancer patients. Genotype-phenotype correlations identified significant differences in the nature of certain extracolonic manifestations in FAP patients belonging to three mutation subgroups. CONCLUSIONS: Extended genotype-phenotype correlations made in this study may have the potential to determine the most appropriate surveillance and prophylactic treatment regimens for those patients with mutations associated with life threatening conditions. This study also provided evidence for the pathological nature of amino acid changes in APC associated with both FAP and non-FAP colorectal cancer patients.
BACKGROUND/AIMS: The development of colorectal cancer and a variable range of extracolonic manifestations in familial adenomatous polyposis (FAP) is the result of the dominant inheritance of adenomatous polyposis coli (APC) gene mutations. In this study, direct mutation analysis of the APC gene was performed to determine genotype-phenotype correlations for nine extracolonic manifestations and to investigate the incidence of APC mutations in non-FAP colorectal cancer. METHODS: The APC gene was analysed in 190 unrelated FAP and 15 non-FAP colorectal cancerpatients using denaturing gradient gel electrophoresis, the protein truncation test, and direct sequencing. RESULTS: Chain terminating signals were only identified in patients belonging to the FAP group (105 patients). Amino acid changes were identified in four patients, three of whom belonged to the non-FAP group of colorectal cancerpatients. Genotype-phenotype correlations identified significant differences in the nature of certain extracolonic manifestations in FAPpatients belonging to three mutation subgroups. CONCLUSIONS: Extended genotype-phenotype correlations made in this study may have the potential to determine the most appropriate surveillance and prophylactic treatment regimens for those patients with mutations associated with life threatening conditions. This study also provided evidence for the pathological nature of amino acid changes in APC associated with both FAP and non-FAP colorectal cancerpatients.
Authors: F MacDonald; D G Morton; P M Rindl; J Haydon; R Cullen; J Gibson; J P Neoptolemos; M R Keighley; C M McKeown; M Hultén Journal: BMJ Date: 1992-04-04
Authors: Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen Journal: Proc Natl Acad Sci U S A Date: 1992-05-15 Impact factor: 11.205
Authors: G Joslyn; M Carlson; A Thliveris; H Albertsen; L Gelbert; W Samowitz; J Groden; J Stevens; L Spirio; M Robertson Journal: Cell Date: 1991-08-09 Impact factor: 41.582
Authors: H Nagase; Y Miyoshi; A Horii; T Aoki; G M Petersen; B Vogelstein; E Maher; M Ogawa; M Maruyama; J Utsunomiya Journal: Hum Mutat Date: 1992 Impact factor: 4.878
Authors: K W Kinzler; M C Nilbert; L K Su; B Vogelstein; T M Bryan; D B Levy; K J Smith; A C Preisinger; P Hedge; D McKechnie Journal: Science Date: 1991-08-09 Impact factor: 47.728
Authors: R Fodde; R van der Luijt; J Wijnen; C Tops; H van der Klift; I van Leeuwen-Cornelisse; G Griffioen; H Vasen; P M Khan Journal: Genomics Date: 1992-08 Impact factor: 5.736
Authors: Y L Wallis; F Macdonald; M Hultén; J E Morton; C M McKeown; J P Neoptolemos; M Keighley; D G Morton Journal: Hum Genet Date: 1994-11 Impact factor: 4.132
Authors: Amy McCart; Andrew Latchford; Emmanouil Volikos; Andrew Rowan; Ian Tomlinson; Andrew Silver Journal: Fam Cancer Date: 2006 Impact factor: 2.375
Authors: W Friedl; R Caspari; M Sengteller; S Uhlhaas; C Lamberti; M Jungck; M Kadmon; M Wolf; J Fahnenstich; J Gebert; G Möslein; E Mangold; P Propping Journal: Gut Date: 2001-04 Impact factor: 23.059
Authors: Fábio Guilherme Campos; Carlos Augusto Real Martinez; Marleny Novaes; Sérgio Carlos Nahas; Ivan Cecconello Journal: Fam Cancer Date: 2015-06 Impact factor: 2.375
Authors: Per Arne Andresen; Ketil Heimdal; Kristin Aaberg; Katrine Eklo; Kristin Eklo; Sarah Ariansen; Alexandra Silye; Olav Fausa; Lars Aabakken; Stefan Aretz; Tor J Eide; Tobias Gedde-Dahl Journal: J Cancer Res Clin Oncol Date: 2009-05-15 Impact factor: 4.553